David Nutt was paid by drug companies

According to a leaked House of Commons report, cited by News of the World, the former chair of the British ACMD (Advisory Council on the Misuse of Drugs), David Nutt, got up to £30,000 a year from firms such as Glaxo Smith Kline and John Wyeth.